10:57 AM EST - Zenabis Global Inc. : Has entered into a binding term sheet for a three-year supply arrangement with leading German pharmaceutical research company Farmako GmbH for: (1) the supply of biosynthetically produced pure CBD isolate oil (99.9%) from Farmako to Zenabis for sale in Canada; and (2) the supply of European Union Good Manufacturing Practices certified cannabis cultivated in Zenabis' indoor facilities in Canada for sale by Farmako to the German medical market. Zenabis Global Inc.
shares V.ZENA are trading up $0.01 at $1.82.